-+ 0.00%
-+ 0.00%
-+ 0.00%

Telomir Pharmaceuticals Inc. Announces Promising Preclinical Results for Telomir-1 in Aggressive Prostate Cancer, Highlighting Potential Breakthrough in DNA Methylation Reset Therapy

Reuters·09/09/2025 11:31:47

Please log in to view news